Hematopoietic stem-cell transplantation following solid-organ transplantation in children

Bone Marrow Transplantation

Volumn 46, Issue 10, 2011, Pages 1321-1325

  Schechter Finkelstein, T ^a   Gassas, A ^a   Weitzman, S ^a   Grant, D ^a   Pollock Barziv, S ^a   Dipchand, A ^a   Alexander, S ^a   Ali, M ^a   Avitzur, Y ^a   Doyle, J ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

hematopoietic stem cell transplantation; pediatric; solid organ transplantation

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FLUCONAZOLE; FLUDARABINE; GANCICLOVIR; IMMUNOGLOBULIN; MELPHALAN; METHYLPREDNISOLONE; PENICILLIN G; PNEUMOCOCCUS VACCINE; RAPAMYCIN; RIBAVIRIN; TACROLIMUS; THIOTEPA; THYMOCYTE ANTIBODY;

ADENOVIRUS INFECTION; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CANCER RECURRENCE; CASE REPORT; CAUSE OF DEATH; CHILD; COHORT ANALYSIS; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENGRAFTMENT; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEASIBILITY STUDY; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LIVING DONOR; LYMPHOPROLIFERATIVE DISEASE; MALE; MULTIPLE ORGAN FAILURE; MYCOSIS; PNEUMOCOCCAL INFECTION; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL TIME; T CELL LYMPHOMA; TREATMENT OUTCOME; VIRUS REACTIVATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; ORGAN TRANSPLANTATION; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 80054001151     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.153     Document Type: Article

References (30)

1. Mangat JS, Rao K, Kingston J, Veys P, Amrolia P, Burch M. Early pediatric antracycline cardiotoxicity: managed be serial heart and bone marrow transplantation. J Heart Lung Transplant 2007; 26: 658-660. (Pubitemid 46818051)
2. Kawahara K, Storb R, Sanders J, Petersen FB. Successful allogeneic bone marrow transplantation in a 6.5-year-old male for severe aplastic anemia complicating orthotopic liver transplantation for fulminant non-A-non-B hepatitis. Blood 1991; 78: 1140-1143.
3. Hagglund H, Winiarski J, Ringden O, Sparrelid E, Ericzon BG. Successful allogeneic bone marrow transplantation in a 2.5-year-old boy with ongoing cytomegalovirus viremia and severe aplastic anemia after orthotopic liver transplantation for non-A, non-B, non-C hepatitis. Transplant 1997; 64: 1207-1208. (Pubitemid 27467952)
4. Trede NS, Warwick AB, Rosoff PM, Rohrer R, Bierer BE, Guinan E. Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation. Bone Marrow Transplant 1997; 20: 257-260. (Pubitemid 27361921)
5. Perkins JL, Neglia JP, Ramsay NKC, Davies SM. Successful bone marrow transplantation for severe aplastic anemiafollowing orthotopic liver transplantation: long-term followup and outcome. Bone Marrow Transplant 2001; 28: 523-526. (Pubitemid 33069633)
6. Yoshimi A, Nnny Y, Ueda K, Asano D, Yamamoto G, Kumano K. successful hematopoietic stem cell transplantation from an HLA-identical sibling in a patient with aplastic anemia and HLA-haploidentical living-related liver transplantation for fulminant hepatitis. Biol Blood Marrow Transplant 2009; 15: 389-390.
7. Manlhiot C, Pollock-Barziv SM, Holmes S, Weitzman S, Allen U, Clarizia NA et al. Post transplant lymphoproliferative disorders in pediatric heart transplant patients. J Heart Lung Transplant 2010; 29: 648-657.
8. Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). Immunodeficiency associated lymphoproliferative disorders. In: Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. IARC Press: Lyon, 2001.
9. Langer RM, Jaray J, Toth A, Hi?dve?gi M, Ve?gso? G, Perner F et al. De novo tumors after kidney transplantation: the Budapest experience. Transplant Proc 2003; 35: 1396-1398. (Pubitemid 36765542)
10. Penn I. Cancers in renal transplant recipients. Adv Ren Replace Ther 2000; 7: 147-156-. (Pubitemid 30196783)
11. Dharnidharka VE, Tejani AH, Ho PL. Posttransplant lymphoproliferative disorder in the United States: young Caucasian males are at higher risk. Am J Transplant 2002; 2: 993-998. (Pubitemid 36330232)
12. Herzig KA, Juffs HG, Norris D, Brown AM, Gill D, Hawley CM et al. A single-center experience of post-renal transplant lymphoproliferative disorder. Transplant Int 2003; 16: 529-536. (Pubitemid 36975574)
13. Webber SA, Naftel DC, Fricker FJ, Olesnevich P, Blume ED, Addonizio L et al. Pediatric Heart Transplant Study. Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet 2006; 367: 233-239. (Pubitemid 43107668)
14. Yousem SA, Randhawa P, Locker J, Paradis IL, Dauber JA, Griffith BP et al. Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol 1989; 20: 361-369. (Pubitemid 19102128)
15. Nalesnik MA. Clinicopathologic features of posttransplant lymphoproliferative disorders. Ann Transplant 1997; 4: 33-40.
16. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V et al. Defining the intensity of conditioning regimens: working definition. Biol Blood Marrow Transplant 2009; 15: 1628-1633.
17. Chiang KY, Lazarous HM. Should we be performing more combined hematopoietic stem cell plus solid organ transplants? Bone Marrow Transplant 2003; 31: 633-642. (Pubitemid 36553472)
18. Kobbe G, Germing U, Aivado M, Zohren F, Schubert D, Strupp C et al. Treatment of secondary myelodysplastic syndrome after heart transplantation with chemotherapy and nonmyeloablative stem-cell transplantation. Transplantation 2002; 74: 1198-1200. (Pubitemid 35216121)
19. Haldas J, Wang W, Lazarchick J. Post-transplant lymphoproliferative disorders: T-cell lymphoma following cardiac transplant. Leukemia Lymphoma 2002; 43: 447-450. (Pubitemid 34202132)
20. Draoua HY, Tsao L, Mancini DM, Addonizio LJ, Bhagat G, Alobeid B. T-cell post-transplantation lymphoproliferative disorders after cardiac transplantation: a single institutional experience. Br J Haematol 2004; 127: 429-432. (Pubitemid 39536595)
21. Rajakariar R, Bhattacharyya M, Norton A, Sheaff M, Cavenagh J, Raftery MJ et al. Post-transplant T-cell lymphoma: a case series of four patients from a single unit and review of the literature. Am J Transplant 2004; 4: 1534-1538. (Pubitemid 39159070)
22. Lundell R, Elenitoba-Johnson KS, Lim MS. T-cell posttransplant lymphoproliferative disorder occurring in a pediatric solid-organ transplant patient. Am J Surg Pathol 2004; 28: 967-973. (Pubitemid 38856856)
23. Williams KM, Higman MA, Chen AR, Schwartz CL, Wharam M, Colombani P et al. Successful treatment of a child with late onset T-cell post transplant lymphoproliferative disorder/ lymphoma. Pediatr Blood Cancer 2008; 50: 667-670. (Pubitemid 351155854)
24. Feyler S, Prince HM, Pearce R, Towlson K, Nivison-Smith I, Schey S et al. The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study. Bone Marrow Transplant 2007; 40: 443-450. (Pubitemid 47288223)
25. Dai QY, Souillet G, Bertrand Y, Galambrun C, Bleyzac N, Manel AM et al. Antileukemic and long-term effects of two regimens with or without TBI in allogeneic bone marrow transplantation for childhood lymphoblastic leukemia. Bone Marrow Transplant 2004; 34: 667-673. (Pubitemid 39406050)
26. Thaunat O, Alyanakian MA, Varnous S, Bors V, Damaj G, Rerolle JP et al. Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosis. Bone Marrow Transplant 2005; 35: 419-420. (Pubitemid 40309490)
27. Tzakis AG, Arditi M, Whitington PF, Yanaga K, Esquivel C, Andrews WA et al. Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. New Engl J Med 1988; 319: 393-396.
28. Cattral MS, Langnas AN, Markin RS, Antonson DL, Heffron TG, Fox IJ et al. Aplastic anemia after liver transplantation for fulminant liver failure. Hepatology 1994; 20: 813-818. (Pubitemid 24296485)
29. Dey B, Sykes M, Spitzer TR. Outcomes of recipients of both bone marrow and solid organ transplants. A review. Medicine (Baltimore) 1998; 77: 355-369. (Pubitemid 28449836)
30. Hadzic N, Height S, Ball S, Rela M, Heaton ND, Veys P. Evolution in the management of acute liver failure-associated aplastic anaemia in children: a single centre experience. J Hepatol 2008; 48: 68-73. (Pubitemid 350191995)